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Abstract
Background:  Patients  with  intestinal  failure  are  unable  to  maintain  adequate  nutrition  and
hydration  due  to  a  reduction  in  the  functional  area  of  the  intestine.  Different  strategies  have
the potential  to  beneﬁt  these  patients  by  promoting  intestinal  autonomy,  enhancing  quality  of
life, and  increasing  survival.
Aims:  To  describe  the  clinical  characteristics  of  children  with  intestinal  failure  and  disease
progression  in  terms  of  intestinal  autonomy  and  survival.
Materials  and  methods:  A  retrospective  study  was  conducted,  evaluating  33  pediatric  patients
with intestinal  failure  that  were  hospitalized  within  the  time  frame  of  December  2005  and
December  2013  at  a  tertiary  care  referral  center.  Patient  characteristics  were  described  upon
hospital admission,  estimating  the  probability  of  achieving  intestinal  autonomy  and  calculating
the survival  rate.
Results:  Patient  median  age  upon  hospital  admission  was  2  months  (interquartile  range  [IQR]:
1-4 months)  and  54.5%  of  the  patients  were  boys.  Intestinal  autonomy  was  achieved  in  69.7%
of the  cases  with  a  median  time  of  148  days  (IQR:  63  -  431  days),  which  decreased  to  63  days  in
patients  with  a  spared  ileocecal  valve.  Survival  was  91%  during  a  median  follow-up  of  281  days
(IQR: 161  -  772  days).
 Please cite this article as: Contreras-Ramírez MM, Giraldo-Villa A, Henao-Roldan C, Martínez-Volkmar MI, Valencia-Quintero AF, Montoya-
Delgado DC, et al. Evolución en nin˜os con falla intestinal en un hospital de referencia en Medellín, Colombia. Revista de Gastroenterología
de México. 2016;81:21--27.
∗ Corresponding author. Calle 78B N.◦ 69-240. Hospital Pablo Tobón Uribe. Segundo piso. Oﬁcina de ayudas diagnósticas. Medellín, Colombia,
Código Postal 3466 Telephone: (57-4) 445 9000, ext. 9276.
E-mail address: gastroconsulta@gmail.com (M.M. Contreras-Ramírez).
2255-534X/© 2015 Published by Masson Doyma México S.A. on behalf of Asociación Mexicana de Gastroenterología. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
22  M.M.  Contreras-Ramírez  et  al.
Conclusions:  Medical  management  of  patients  with  intestinal  failure  is  complex.  Nutritional
support and  continuous  monitoring  are  of  the  utmost  importance  and  long-term  morbidity  and
mortality  depends  on  the  early  recognition  and  management  of  the  associated  complications.
© 2015  Published  by  Masson  Doyma  México  S.A.  on  behalf  of  Asociación  Mexicana
de Gastroenterología.  This  is  an  open  access  article  under  the  CC  BY-NC-ND  license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Evolución  en  nin˜os  con  falla  intestinal  en  un  hospital  de  referencia  en  Medellín,
Colombia
Resumen
Antecedentes:  Los  pacientes  con  falla  intestinal  son  incapaces  de  mantener  una  adecuada  nutri-
ción e  hidratación  debido  a  una  reducción  en  el  área  intestinal  funcional.  La  implementación
de diferentes  estrategias  tiene  el  potencial  de  beneﬁciar  a  estos  pacientes  en  términos  de
favorecer la  autonomía  intestinal,  aumentar  la  calidad  de  vida  y  elevar  la  supervivencia.
Objetivos:  Describir  las  características  clínicas  de  nin˜os  con  falla  intestinal,  así  como  la  evolu-
ción en  términos  de  autonomía  intestinal  y  supervivencia.
Materiales  y  métodos: Estudio  retrospectivo  en  el  que  se  evaluó  a  33  pacientes  pediátricos  con
falla intestinal,  hospitalizados  entre  diciembre  del  2005  y  diciembre  del  2013  en  una  institución
de alta  especialidad.  Se  describieron  las  características  de  los  pacientes  al  ingreso  hospitalario,
se estimó  la  probabilidad  de  lograr  la  autonomía  intestinal  y  se  calculó  la  tasa  de  supervivencia.
Resultados:  La  mediana  de  edad  al  momento  de  ingresar  al  hospital  fue  2  meses  (rango
intercuartílico  [RIC]:  1-4  meses)  y  el  54.5%  de  los  pacientes  fueron  de  sexo  masculino.  El
69.7% de  los  casos  lograron  la  autonomía  intestinal  con  una  mediana  de  tiempo  de  148  días
(RIC: 63-431  días),  la  cual  disminuyó  a  63  días  cuando  los  pacientes  tenían  presencia  de  válvula
ileocecal. La  supervivencia  fue  del  91%  durante  una  mediana  se  seguimiento  de  281días  (RIC:
161-772 días).
Conclusiones:  El  manejo  médico  de  los  pacientes  con  falla  intestinal  es  complejo.  El  soporte
nutricional  y  la  monitorización  continua  son  de  vital  importancia  y  la  morbimortalidad  a  largo
plazo depende  del  reconocimiento  y  manejo  precoz  de  las  complicaciones  asociadas.
© 2015  Publicado  por  Masson  Doyma  México  S.A.  en  nombre  de  Asociación  Mexicana
de Gastroenterología.  Este  es  un  artículo  Open  Access  bajo  la  licencia  CC  BY-NC-ND
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ntestinal  failure  in  pediatrics  can  be  deﬁned  as  the  reduc-
ion  of  the  intestinal  mass  below  the  minimum  necessities
or  maintaining  adequate  digestion  and  absorption  of  nutri-
nts  and  ﬂuids  necessary  for  growth.1,2
A  number  of  diseases  are  recognized  as  being  respon-
ible  for  this  entity,  and  the  most  common  is  short  bowel
yndrome  (SBS).  Others  are  structural  abnormalities  of  the
nterocyte,  inﬂammatory  alterations,  severe  food  aller-
ies,  autoimmune  enteropathies,  and  severe  bowel  transit
isorders.3
Adequate  nutrient  absorption  and  growth  involve  a pro-
ess  of  intestinal  adaptation  that  will  depend  on  the
xtension,  functionality,  and  motility  of  the  intestinal  rem-
ant.  The  clinical  course  of  these  patients  for  achieving
ntestinal  adaptation  is  long  and  complex.  The  maximum
ntestinal  adaptation  time  estimated  in  adults  is  2  years,  but
n  children  it  can  last  longer  than  3  years.4,5The  treatment
f  these  children  is  based  on  the  provision  of  adequate  nutri-
ion:  total  parenteral  nutrition  (TPN)  plus  enteral  nutrition
EN)  when  possible,  thus  promoting  intestinal  adaptation.
A
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Tt  also  requires  the  prevention  and/or  treatment  of  the
omplications  derived  from  the  underlying  disease  or  sec-
ndary  to  prolonged  TPN  use.6
The  multidisciplinary  programs  focused  on  the  integrated
reatment  of  these  patients  has  dramatically  changed  the
urvival  of  these  children  over  the  last  decades.7--9 The  care
f  these  patients  at  our  hospital  is  guided  by  a  group  of
rofessionals  under  a  protocol  that  has  the  possibility  of
ndividualizing  each  case  and  it  continues  to  evolve  as  new
vidence  is  brought  to  light.
The  aim  of  this  study  was  to  describe  the  clinical  charac-
eristics,  such  as  progression  in  terms  of  intestinal  autonomy
nd  survival,  in  a group  of  pediatric  patients  with  intestinal
ailure  treated  at  a  tertiary  care  referral  center.
opulation and methods retrospective  study  was  carried  out  that  included  33
ediatric  patients  hospitalized  within  the  time  frame  of
ecember  2005  and  December  2013  at  the  Hospital  Pablo
obón  Uribe, an  advanced  specialty  institution  and  center
ospital  in  Medellín,  Colombia  23
Table  1  Initial  characteristics  of  the  study  population.
Population  total
n =  33
Age  in  months  upon  hospital  arrival,
median  (IQR)
2  (1  -  4)
Sex, n  (%)
Female  15  (45.5)
Male 18  (54.5)
Age at  the  time  of  resection,  n  (%)
First month  of  life  28  (84.8)
Between  the  ﬁrst  month  and  one
year  of  life
3  (9.1)
Between  one  and  5  years  of  life  1  (3.0)
After 10  years  of  life  1  (3.0)
Extent of  intestinal  resection,  n  (%)
Large  (residual  intestine  between
40  and  100  cm)
19  (57.6)
Massive  (residual  intestine  under
40 cm)
5  (15.2)
Ultra-short  bowel  syndrome
(residual  intestine  under  15  cm)
2  (6.1)
No datum 7  (21.2)
Cause of  resection,  n  (%)
Intestinal  atresia  10  (30.3)
Necrotizing  enterocolitis  8  (24.2)
Intestinal  invagination  4  (12.1)
Intestinal  atresia  and
gastroschisis/Hirschsprung’s
disease
4  (12.1)
Volvulus  and  malrotation  3  (9.1)
Motility  disorder  2  (6.1)
Hirschsprung’s  disease 1  (3.0)
Gastroschisis  1  (3.0)
Residual  intestine  in  cm,  median
(IQR)
60  (35  -  95)
N
T
h
f
e
s
E
w
E
T
g
nProgression  in  children  with  intestinal  failure  at  a  referral  h
of  intestinal  rehabilitation  and  transplantation,  located  in
the  city  of  Medellín,  Colombia.
The  study  included  patients  under  18  years  of  age
presenting  with  intestinal  failure  and  undergoing  TPN,  eval-
uated  by  the  pediatric  nutritional  support  group  of  the
hospital.  There  were  no  exclusions.
The  probability  of  patients  achieving  intestinal  auton-
omy  was  estimated.  Intestinal  autonomy  was  deﬁned  as
the  capacity  to  develop  structural  and  physiologic  changes
following  intestinal  resection  and  that  is  seen  upon  the
suspension  of  parenteral  nutrition,  100%  tolerance  of
nutritional  requirements  through  enteral  feeding,  and  main-
tenance  of  the  expected  level  of  growth.10
All  the  information  was  gathered  from  the  medical  his-
tories  of  the  patients  and  so  informed  consent  from  the
families  was  not  required.  Before  the  collection  of  data,
a  pilot  test  was  conducted  on  a  simple  random  sample  of
10%  of  the  initial  population  in  order  to  test  and  adjust  the
process  and  the  data-gathering  instrument.
Statistical  analysis
The  qualitative  variables  were  expressed  through  frequen-
cies  and  percentages  and  the  quantitative  variables  through
median  and  interquartile  range  (IQR).  The  latter  variables
showed  abnormal  distribution  through  the  Shapiro-Wilk  test.
The  probability  of  achieving  intestinal  autonomy  dur-
ing  treatment  time  was  estimated  using  the  Kaplan-Meier
method  and  comparisons  were  made  with  the  log-rank  test.
The  event  was  to  achieve  intestinal  autonomy  and  the  cen-
sured  cases  were  the  deaths,  transplantations,  or  patients
for  whom  there  was  no  follow-up.
In  all  cases,  statistical  signiﬁcance  was  set  at  a  p  <  0.05
and  the  Windows  SPSS  version  19.0  software  program  was
used.
Results
The  study  included  33  children,  and  54.5%  were  boys.  There
was  a  predominance  of  boys  under  the  age  of  2  years,  repre-
senting  75.8%  of  the  study  population.  A  total  of  18.2%  of  the
patients  arrived  at  the  hospital  in  the  neonatal  period  and
6%  were  older  than  2  years  of  age.  The  median  age  upon  hos-
pital  admission  was  2  months  (IQR:  1-4  months).  The  median
hospital  and  outpatient  follow-up  of  these  patients  was  281
days  (IQR:  161  -  772  days).
The  majority  of  patients  underwent  intestinal  resection
the  ﬁrst  month  of  life  (84.8%),  and  the  5  primary  causes
were:  intestinal  atresia  (30.3%),  necrotizing  enterocolitis
(NEC)  (24.2%),  intestinal  atresia  plus  gastroschisis  (12.1%),
intestinal  invagination  (12.1%),  and  volvulus  or  malrotation
(9.1%).
Due  to  the  fact  that  some  of  the  patients  were  referred
from  other  hospitals,  the  classiﬁcation  of  the  extent  of
resection  was  available  in  only  26  patients;  73.1%  of  them
presented  with  large  intestinal  resection  (residual  intes-
tine  between  40  and  100  cm),  19.2%  with  massive  resection
(residual  intestine  residual  under  40  cm),  and  7.7%  with
ultra-short  bowel  syndrome  (residual  intestine  under  15  cm).
The  colon  was  spared  in  all  33  patients  and  the  ileocecal
valve  was  spared  in  8  patients  (Table  1).
w
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tPresence  of  ileocecal  valve  8  (24.2)
Presence  of  colon  33  (100)
utritional  treatment
he  predominant  type  of  support  during  treatment  in  the
ospital  was  mixed  (TPN  and  EN)  in  75.8%  of  the  cases,
ollowed  by  TPN  plus  oral  nutrition,  exclusive  TPN  (6.1%),
xclusive  EN  (3.0%),  and  exclusive  oral  nutrition  (3.0%).  It
hould  be  mentioned  that  the  cases  that  received  exclusive
N  or  oral  nutrition  were  referred  from  other  hospitals  in
hich  they  had  received  prolonged  TPN.
nteral  nutrition  or  oral  nutrition
hirty-one  hospitalized  patients  received  food  through  the
astrointestinal  tract  in  the  form  of  enteral  nutrition  or  oral
utrition.  In  61.3%  of  the  patients  this  manner  of  feeding
as  begun  through  a  catheter  with  continuous  infusion  and
he  rest  of  the  patients  had  oral  nutrition.  The  initial  hospi-
al  formula  used  was  based  on  free  amino  acids  in  67.7%  of
he  patients,  on  an  extensively  hydrolyzed  formula  (EHF)  in
24  M.M.  Contreras-Ramírez  et  al.
Table  2  Progression  according  to  the  extent  of  intestinal  resection.
Variable/extent  of  resection  Large  Massive  Ultra-short  bowel
syndrome
Undetermined
Number  of  patients  19  5  2  7
Days with  TPNa,  median
(IQR)
60  (18-83)  364  (239-452)  198  (134-263)  42  (8-68)
Intestinal adaptation,  n  (%)  15  (78.9)  1  (20)  0  (0)  7  (100)
Days to  achieve  intestinal
autonomy,  median  (IQR)
148  (81-314)  431  –  41(32-80)
Survival 17  (89.5)  5  (100)  1(50)  7(100)
Transplantationb 0  2  (40) 0  0
IQR: interquartile range; TPN: total parenteral nutrition
a Days with parenteral nutrition at the Hospital Pablo Tobón Uribe. No information was available as to the days of previous parenteral
nutrition in patients referred from other hospitals.
b only up to the transplantation date. Post-transplantation nutritional
study.
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The probability  of  adaptation  according  to  the  initial  type
of  EN  administration  (continuous  infusion  vs  oral  nutrition)
was  compared  and  showed  no  signiﬁcant  differences  (log-
rank  test,  p  =  0.68).
Discussion
The  management  of  patients  with  intestinal  failure  is  com-
plex,  requiring  highly  qualiﬁed  personnel  from  different
1.0
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0.0
0.00 90.00 180.00 270.00 360.00
Days
N
um
be
r o
f p
at
ie
nt
s 
th
at
 a
ch
ie
ve
 in
te
st
in
al
 a
ut
on
om
y
450.00 540.00 630.00 720.00 810.00
Survival functionThe information on the transplanted patients was collected 
treatment and ﬁnal outcome were not considered in the present 
9.3%,  and  on  a  polymeric  formula  in  12.9%.  A  total  of  48.4%
f  the  patients  did  not  tolerate  the  ﬁrst  formula  provided  by
he  hospital,  but  this  did  not  seem  to  be  related  to  the  type
f  administration  (intolerance  to  continuous  infusion:  47.4%,
ral  nutrition:  50%).
arenteral  nutrition
PN  was  administered  to  31  of  the  33  patients  during  their
ospital  stay.  Although  the  other  2  patients  had  received  TPN
t  some  point  during  their  illness,  it  was  suspended  before
heir  admission  to  our  hospital.  Median  TPN  duration  at  our
nstitution  was  68  days  (IQR:  21-138  days).  The  TPN  cycling
eriod  was  2  to  12  h  in  accordance  with  the  conditions  of
he  patient  and  was  carried  out  in  8  cases.
Three  patients  had  outpatient  parenteral  nutrition.
ntestinal  failure  progression
uring  the  median  follow-up  of  281  days  (IQR:  161-772  days),
9.7%  of  the  patients  achieved  intestinal  autonomy,  15.1%
ere  released  from  the  hospital  without  having  achieved
utonomy,  and  9.1%  died  during  the  process  due  to  septic
hock  (2  cases)  and  bowel  obstruction  with  deteriorating
ondition  (one  case).  During  the  treatment,  the  multidisci-
linary  team  also  determined  that  2  patients  (6.1%)  should
ndergo  bowel  transplantation  (Table  2).
The  median  time  for  achieving  intestinal  autonomy  was
48  days  (IQR:  63-431  days).  Six  months  after  treatment,  the
robability  of  reaching  autonomy  was  61.2%  and  at  one  year
fter  treatment  it  was  close  to  72.3%  (Fig.  1).
Intestinal  adaptation  was  achieved  in  87.5%  of  the
atients  with  an  intact  ileocecal  valve,  whereas  it  was
chieved  in  64%  without  an  ileocecal  valve.  The  median  time
equired  for  intestinal  adaptation  in  patients  with  an  ileoce-
al  valve  was  63  days  (IQR:  41-139  days),  compared  with  154
ays  (IQR:  81-479  days)  in  the  patients  without  one.  There
ere  signiﬁcant  differences  upon  comparing  the  likelihood
f  adaptation  according  to  the  presence  or  absence  of  an
leocecal  valve  (log-rank  test,  p  =  0.029)  (Fig.  2).
Censured
Figure  1  Probability  of  achieving  intestinal  autonomy  in
patients with  intestinalfailure  (n  =  33).
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a  median  9-month  follow-up  period.  This  result  was  alsoFigure  2  Probability  of  achieving  intestinal  autonomy  in
patients with  intestinalfailure  (n  =  33)  (log-rank  test,  p  =  0.029).
specialties  that  form  part  of  an  intestinal  rehabilitation
program,  in  order  to  achieve  the  primary  aim  of  enteral
autonomy.  The  advances  of  the  last  few  years  in  the  diag-
nosis  and  treatment  of  intestinal  failure  have  improved
the  survival  rate  of  children  with  this  pathology.  Optimum
management  of  these  patients  includes  both  intestinal  reha-
bilitation  and  enhanced  quality  of  life.11
Even  though  the  results  of  our  study  show  that  the  main
causes  of  intestinal  failure  in  our  population  concur  with
studies  conducted  in  Europe  and  the  United  States,1214 it
was  surprising  that  the  ﬁrst  2  causes  in  a  French  study  were
gastroschisis  and  volvulus,13 and  NEC  and  gastroschisis  in  one
from  the  United  States,12,14 whereas  in  our  population  it  was
intestinal  atresia  and  NEC.  This  could  be  related  to  regional
differences  in  regard  to  genetic  susceptibility,  the  possibility
of  early  access  to  hospital  centers  with  neonatal  intensive
care  units,  and  differences  in  the  South  American  health
systems  from  those  of  Europe  and  the  United  States.
The  work  protocol  of  the  Hospital  Pablo  Tobón  Uribe
includes  adaptation  stimulation  through  EN,  beginning  with
continuous  infusion  and  progressing  to  boluses  and  oral
nutrition.  One  of  the  topics  that  is  still  a  subject  of  debate
among  clinicians  in  regard  to  nutritional  support  in  children
with  intestinal  failure  is  the  manner  of  nutrition  adminis-
tration  (continuous  or  with  boluses)  and  the  composition  of
the  formula  (polymeric,  elemental,  or  semi-elemental).11,15
Some  authors  have  demonstrated  that  continuous  infusion
administration  could  increase  the  absorption  percentage  of
lipids,  proteins,  and  energy,  compared  with  bolus  admin-
istration,  by  maximizing  transport  protein  saturation.15,16
In  our  study,  EN  through  continuous  infusion  was  initially
used  in  a  little  over  half  of  the  patients  (61.3%),  and  oral
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utrition  was  begun  in  the  other  38.7%  due  to  the  fact  that
he  patients  were  admitted  with  this  feeding  regimen  and
hey  had  no  history  of  intolerance.  No  differences  were
ound  upon  comparing  the  probability  of  intestinal  autonomy
nd  the  type  of  initial  administration.
With  respect  to  the  ideal  formula  for  beginning  enteral
eeding,  better  tolerance  with  the  use  of  free  amino  acids
as  been  described  in  animal  models  with  SBS17 and  case
eports  in  humans.18 However,  other  studies  showed  no  dif-
erences  in  the  absorption  of  proteins,  permeability,  and
ntestinal  adaptation  with  the  use  of  an  EHF  or  a  whole-
rotein  formula.15,19 In  our  case  series,  formulas  based  on
ree  amino  acids  were  used  in  67.7%  of  the  patients,  whether
ndicated  by  the  gastroenterologist  or  because  of  prior  intol-
rance  to  EHF  and/or  maternal  breast  milk.
In  relation  to  TPN  use,  the  median  duration  at  our  hospi-
al  was  68  days  (IQR:  21-138  days).  Both  the  United  States
nd  European  literature  reported  a median  duration  of  229
ays  (IQR:  129-408  days)  in  a group  of  patients  from  Boston7
nd  292  days  (IQR:  146-438  days)  in  a  Finnish  study.20 It  is
mportant  to  point  out  that  in  our  study  we  were  not  able
o  determine  the  number  of  days  of  TPN  prior  to  admission
o  our  hospital  and  therefore  the  TPN  time  of  those  patients
ould  actually  be  longer  than  that  reported.
Taking  into  account  that  prolonged  hospital  stay  can
ffect  psychomotor  development  and  quality  of  life,  outpa-
ient  TPN  should  be  considered  as  soon  as  possible  in  children
ith  severe  intestinal  failure.13 Of  the  total  of  patients  that
eceived  TPN,  9.7%  had  outpatient  management,  a  lower
gure  than  that  reported  in  the  French  study  in  which  that
trategy  was  used  in  40.7%  of  the  patients.13 This  underlines
he  local  need  for  improving  health  programs  for  at-home
are  and  parenteral  nutrition.
Enteral  autonomy  continues  to  be  the  fundamental  aim  of
ntestinal  rehabilitation  programs.  According  to  a  2013  sys-
ematic  review,  the  percentage  of  patients  that  achieved
utonomy  varied  from  42  to  84%  through  different  reha-
ilitation  programs,  during  a  follow-up  period  of  12  to
0  months.9 Our  study  showed  that  69.7%  of  the  patients
chieved  intestinal  autonomy,  a  result  concurring  with  that
eported  in  the  systematic  review  and  in  more  recent  stud-
es,  such  as  one  conducted  in  2015  by  Demehri  et  al.  that
howed  intestinal  autonomy  in  64.3%  of  the  patients.14
The  median  time  necessary  to  achieve  intestinal  auton-
my  was  148  days.  Some  studies  show  a  median  of  7621
nd  117  days22, indicating  the  variability  involved  and  the
ependence  on  anatomic  factors,  intestinal  remnant  func-
ion,  and  complications  that  can  arise  during  progression.23
or  example,  in  our  study,  the  presence  of  the  ileocecal
alve  was  shown  to  be  a  factor  that  contributed  to  intestinal
utonomy  achievement  (log-rank  test,  p  =  0.029).  A  Cana-
ian  study  reported  that  the  presence  of  the  ileocecal  valve
as  a  signiﬁcant  predictor  for  adaptation  time  in  the  univari-
te  analysis  and  despite  the  fact  that  it  was  not  included  in
he  ﬁnal  multivariate  model,  it  was  shown  to  be  an  impor-
ant  predictor  for  the  intestinal  adaptation  result  in  various
odels.14,24,25
The  survival  rate  was  91%  in  the  33  patients  that  hadn  accordance  with  other  small  cohort  studies  that  demon-
trated  survival  rates  of  89%  (48/54)7 and  even  100%  (31/31),
hen  standardized  care  protocols  were  applied.22 Other
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26  
tudies  with  longer  follow-up  periods  reported  survival  rates
f  85%14 and  up  to  71%  in  a  cohort  of  114  patients  with  a
edian  7-year  follow-up.13 A  systematic  review  published
n  2013  stated  that  the  mortality  rate  varied  from  6.4  to
7.5%  among  different  multidisciplinary  programs  and  the
ide  mortality  range  could  be  partially  explained  by  dif-
erences  in  the  baseline  characteristics  of  the  patients.  For
xample,  the  programs  that  reported  high  mortality  rates
ended  to  be  conducted  at  tertiary  care  referral  centers  that
overed  large  geographic  areas,  suggesting  the  possibility  of
ias  in  the  results.9 The  systematic  review  also  pointed  out
hat  the  cause  of  death  was  the  same  in  all  the  programs9
nd  the  ﬁrst  cause  was  sepsis,  as  was  the  case  in  regard  to
ur  patients.
Although  follow-up  after  intestinal  transplantation  was
ot  an  aim  of  the  present  study,  it  should  be  mentioned  that
he  2  patients  that  underwent  transplantation  died  42  and
40  days  after  the  procedure.  Those  deaths  were  secondary
o  cardiorespiratory  infarct  during  control  endoscopy.  The
eath  of  a  third  patient  was  due  to  sepsis  caused  by  mul-
iresistant  Klebsiella  pneumoniae.
Our  study  has  the  limitations  characteristic  of  retrospec-
ive  analyses  that  do  not  allow  the  desired  control  of  the
ature  and  quality  of  the  measurements.  Information  on
he  days  of  TPN  and  management  carried  out  before  admis-
ion  to  our  hospital  was  impossible  to  collect  from  secondary
ources.
In  conclusion,  the  management  of  patients  with  intestinal
ailure  is  complex  and  should  be  performed  by  an  multidisci-
linary  team,  as  demonstrated  in  the  literature,  given  that  it
mproves  survival  and  quality  of  life  in  these  patients.7--9,22,23
n  our  study,  69.7%  of  the  patients  with  intestinal  failure
reated  by  the  pediatric  nutritional  support  group  achieved
ntestinal  adaptation  and  there  was  a  survival  rate  of  91%,
gures  that  are  comparable  with  other  intestinal  rehabili-
ation  programs.  Treatment  of  this  pathology  is  a  challenge
or  the  different  specialists  involved  that  must  always  direct
heir  work  towards  the  achievement  of  intestinal  rehabil-
tation  and  enteral  autonomy.  According  to  our  results,
pportune  referral  to  a  specialized  center  is  highly  recom-
ended  and  has  a  positive  inﬂuence  on  attaining  adequate
ntestinal  autonomy  in  the  majority  of  patients.
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